Benjamin Pelle

Benjamin Pelle

Auto-generated profile, based on publicly available information

Benjamin Pelle

Department of Genome Sciences, University of Washington, Seattle, WA 98195, USA

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 May 2021 in Science Translational Medicine
Verified
Journal Article
Open access
PDF file
NMNicola F. Müller
Nicola F. Müller
CWCassia Wagner
Cassia Wagner
CFChris D. Frazar
Chris D. Frazar
PRPavitra Roychoudhury
Pavitra Roychoudhury
JLJover Lee
Jover Lee
TBTrevor Bedford
Trevor Bedford
Initial SARS-CoV-2 dynamics in Washington State were driven by regional interventions and introductions of variants differing in viral loads.

1 October 2019 in International Journal of Genomics
Verified
Journal Article
Open access
PDF file
AHAndrew Hatch
Andrew Hatch
JHJames Horne
James Horne
RTRyan Toma
Ryan Toma
BTBrittany L. Twibell
Brittany L. Twibell
KSKalie M. Somerville
Kalie M. Somerville
MVMomchilo Vuyisich
Momchilo Vuyisich
A functional readout of the gut microbiome is necessary to enable precise control of the gut microbiome’s functions, which support human health and prevent or minimize a wide range of chronic diseases. Stool metatranscriptomic analysis offers a comprehensive functional view of the gut microbiome, but despite its usefulness, it has rarely been used in clinical studies due to its complexity, cost, and bioinformatic challenges. This method has also received criticism due to potential intrasample variability, rapid changes, and RNA degradation. Here, we describe a robust and automated stool metatranscriptomic method, called Viomega, which was specifically developed for population-scale studies. Viomega includes sample collection, ambient temperature sample preservation, total RNA extraction, physical removal of ribosomal RNAs (rRNAs), preparation of directional Illumina libraries, Illumina sequencing, taxonomic classification based on a database of >110,000 microbial genomes, and quantitative microbial gene expression analysis using a database of ~100 million microbial genes. We applied this method to 10,000 human stool samples and performed several small-scale studies to demonstrate sample stability and consistency. In summary, Viomega is an inexpensive, high-throughput, automated, and accurate sample-to-result stool metatranscriptomic technology platform for large-scale studies and a wide range of applications.

10 August 2020 in BioTechniques
Verified
Journal Article
Open access
RTRyan Toma
Ryan Toma
NDNathan Duval
Nathan Duval
BPBenjamin Pelle
Benjamin Pelle
MPMatthew M Parks
Matthew M Parks
VGVishakh Gopu
Vishakh Gopu
MVMomchilo Vuyisich
Momchilo Vuyisich
To prevent and treat chronic diseases, including cancer, a global application of systems biology is needed. We report here a whole blood transcriptome test that needs only 50 μl of capillary (finge... METHOD SUMMARY This report describes an important improvement to whole blood transcriptome analysis. While current methods are complicated and expensive, the method reported here includes at-home s...

30 September 2020 in medRxiv
Verified
Preprint
Open access
PDF file
NMNicola F. Müller
Nicola F. Müller
CWCassia Wagner
Cassia Wagner
CFChris D. Frazar
Chris D. Frazar
PRPavitra Roychoudhury
Pavitra Roychoudhury
JLJover Lee
Jover Lee
TBTrevor Bedford
Trevor Bedford
The rapid spread of SARS-CoV-2 has gravely impacted societies around the world. Outbreaks in different parts of the globe are shaped by repeated introductions of new lineages and subsequent local transmission of those lineages. Here, we sequenced 3940 SARS-CoV-2 viral genomes from Washington State to characterize how the spread of SARS-CoV-2 in Washington State (USA) was shaped by differences in timing of mitigation strategies across counties, as well as by repeated introductions of viral lineages into the state. Additionally, we show that the increase in frequency of a potentially more transmissible viral variant (614G) over time can potentially be explained by regional mobility differences and multiple introductions of 614G, but not the other variant (614D) into the state. At an individual level, we see evidence of higher viral loads in patients infected with the 614G variant. However, using clinical records data, we do not find any evidence that the 614G variant impacts clinical severity or patient outcomes. Overall, this suggests that at least to date, the behavior of individuals has been more important in shaping the course of the pandemic than changes in the virus. One Sentence Summary Local outbreak dynamics of SARS-CoV-2 in Washington State (USA) were driven by regionally different mitigation measures and repeated introductions of unique viral variants with different viral loads.

23 May 2020 in bioRxiv
Verified
Preprint
Open access
PDF file
RTRyan Toma
Ryan Toma
BPBenjamin Pelle
Benjamin Pelle
NDNathan Duval
Nathan Duval
MPMatthew M Parks
Matthew M Parks
VGVishakh Gopu
Vishakh Gopu
MVMomchilo Vuyisich
Momchilo Vuyisich
Chronic diseases are the leading cause of morbidity and mortality globally. Yet, the majority of them have unknown etiologies, and genetic contribution is weak. In addition, many of the chronic diseases go through the cycles of relapse and remission, during which the genomic DNA does not change. This strongly suggests that human gene expression is the main driver of chronic disease onset and relapses. To identify the etiology of chronic diseases and develop more effective preventative measures, a comprehensive gene expression analysis of the human body is needed. Blood tissue is easy to access and contains a large number of expressed genes involved in many fundamental aspects of our physiology. We report here the development of a whole blood transcriptome clinical test that is high throughput, automated, inexpensive, and clinically validated. The test requires only 50 microliters of blood from a finger prick, enabling access by diverse populations that have been traditionally under-represented in clinical research. The transcripts in the samples are preserved at the time of collection and can be stored and/or transported at ambient temperatures for up to 28 days. The sample preservative protects integrity, while also inactivating all pathogens (bacteria, fungi, and viruses), enabling safe transportation globally. Given its unique set of usability features and clinical performance, this test should be integrated into longitudinal, population-scale, systems biology studies.